Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

From Service Provider to Strategic Partner
As drug development grows more complex and timelines compress, sponsors require CDMO relationships built on integration, flexibility, and shared accountability read more
How AI is Transforming Clinical Trials
AI is already reshaping the clinical trials industry and that transformation looks set to continue over the next five years. New technologies will enable the development of more personalized medicines, empower more responsive trial designs and improve informed decision making by unlocking new data insights. read more
Engaging with Regulators for Single-Arm Oncology Research Trials
When well-planned and well-executed, single-arm trials can accelerate access to life-saving therapies that might otherwise never reach desperate cancer patients. read more
Quality: The Gold Standard for CDMOs - No Exceptions, No Compromises
In today’s hyper-competitive pharmaceutical landscape, innovation, speed-to-market and cost control usually take the spotlight when selecting a contract development and manufacturing organization (CDMO). However, underneath all those metrics, a single truth remains: if quality fails, so does everything else. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma
Monday, May 18, 2026
LOTTE Biologics announced an expansion of its collaboration with Ottimo Pharma, a biotech company developing one-of-a-kind PD-1/VEGFR2 dual-paratopic ... read more
Avid Bioservices Appoints Chief People Officer
Monday, May 18, 2026
Avid Bioservices announced the appointment of Maria Ebro Andreasen as Chief People Officer. The appointment comes as Avid continues to scale its ... read more
Catalent and Elpida Therapeutics Enter Strategic Partnership for Late-Phase AAV Manufacturing
Monday, May 18, 2026
Elpida Therapeutics, a non-profit biotechnology company developing gene therapies for ultra-rare diseases, and Catalent announced a strategic ... read more
Piramal Pharma Solutions Partners with Botanix to Support Drug Substance Development
Monday, May 18, 2026
Piramal Pharma Solutions has entered a manufacturing and supply arrangement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, a ... read more
Agilent and Veeda Lifesciences Collaborate to Accelerate GLP-1 and Complex Biologics Development Services
Thursday, May 14, 2026
Agilent Technologies announced a strategic collaboration with Veeda Lifesciences to strengthen regulatory-aligned analytical and bioanalytical ... read more